|
KMID : 0352720100340040264
|
|
Journal of Ginseng Research
2010 Volume.34 No. 4 p.264 ~ p.273
|
|
|
Current Clinical Evidence for Korean Red Ginseng in Management of Diabetes and Vascular Disease: A Toronto’s Ginseng Clinical Testing Program
|
|
Vuksan Vladimir
Sievenpipper John
Jovanovski Elena
Jenkins Alexandra L.
|
|
|
Abstract
|
|
|
|
While ginseng is reported to have a wide array of applications, there is growing evidence for its indications in diabetes and vascular disease. A clear connection, however, has not been established between ginseng’s composition, dose and its targeted efficacy in humans. We therefore developed and initiated the Korean Red Ginseng Clinical Testing Program for diabetes and vascular function which is an efficacy and safety-based clinical screening model for ginseng. The most efficacious sources, ginsenoside profiles, doses, and modes of administration were examined in sequential, acute, followed by long term, random- acute, followed by long term, random-andomized-controlled trials to investigate the efficacy and safety profiles. This review discusses the current state of the clinical re- This review discusses the current state of the clinical re- research of Korean red ginseng program conducted in Toronto, paving the way for the use of clinically selected ginseng and its ginsenoside fractions in the management of diabetes and vascular diseases.
|
|
|
KEYWORD
|
|
|
Korean red ginseng, Ginsenoside extract, Randomized controlled trial, Glycemic control, Vascular disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|